Crosslinking-Dependent Structure–Transport–Function Relationships in Gelatin–Hyaluronic Acid Hydrogels for Wound-Fluid Management
ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10465-10478
DOI: 10.1021/acsabm.6c01693 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 15.10.2026. Verfasst von Nurdiana Nordin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur50603, Malaysia. Hauptthemen laut MEDLINE: Hyaluronic Acid, Hydrogels, Gelatin, Biocompatible Materials. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Universiti Malaya.
Abstract (Originalsprache)
Effective wound-fluid management is essential in medical applications, as dressings must absorb, retain, and regulate excess blood, exudate, and other biological fluids. Gelatin–hyaluronic acid (Gel/HA) hydrogels are promising dressing materials because they provide a hydrated, tissue-mimetic environment and combine the biological functions of both polymers. Their performance depends strongly on the crosslinking strategy, which regulates network architecture, fluid transport, and mechanical integrity. Three Gel/HA networks were prepared by physical association (Network I), glutaraldehyde-mediated covalent crosslinking (Network II), and PEGDA-mediated interpenetrating-network formation (Network III). Molecular interactions, morphology, fluid uptake, and mechanical properties were evaluated within a structure–transport–function framework. The networks exhibited distinct pore structures, with average pore sizes of 21 ± 7, 2.3 ± 0.8, and 9 ± 3 μm and porosities of 74 ± 3, 59 ± 3, and 67 ± 3% for Networks I–III, respectively. Tensile strength increased from 62 ± 5 kPa for Network I to 127 ± 7 kPa for Network II and 215 ± 9 kPa for Network III, while elongation at break increased from 152 ± 9 to 257 ± 12 and 343 ± 14%, respectively. Simulated blood uptake at 240 min reached 483 ± 45, 842 ± 59, and 1285 ± 72% for Networks I–III, respectively. An integrated hydrogel performance index was used as a comparative dimensionless descriptor of selected transport and mechanical properties. Overall, the results show that network formulation yields distinct combinations of pore architecture, fluid transport, and mechanical performance, providing a basis for comparing Gel/HA hydrogel designs for wound management applications that balance fluid management and mechanical properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Universiti Malaya, Kuala Lumpur50603, Malaysia.
- Department of Engineering and Sciences, American Degree Program, School of Liberal Arts and Sciences, Taylor's University, Taylor's Lakeside Campus, No. 1 Jalan Taylor, Subang Jaya47500, Selangor, Malaysia.
- Centre for Active Living, Taylor's University, Taylor's Lakeside Campus, No. 1 Jalan Taylor, Subang Jaya47500, Selangor, Malaysia.
ORCID-Profile: Nurdiana Nordin, Nurfarhanim Abu Bakar
Förderung
- Universiti Malaya
Zitieren
APA
Nordin, N., Shaharulnizam, M. A., Zamlis, M. A., & Bakar, N. A. (2026). Crosslinking-Dependent Structure–Transport–Function Relationships in Gelatin–Hyaluronic Acid Hydrogels for Wound-Fluid Management. ACS Applied Bio Materials, 9(21), 10465-10478. https://doi.org/10.1021/acsabm.6c01693
Vancouver
Nordin N, Shaharulnizam MA, Zamlis MA, Bakar NA. Crosslinking-Dependent Structure–Transport–Function Relationships in Gelatin–Hyaluronic Acid Hydrogels for Wound-Fluid Management. ACS Applied Bio Materials. 2026;9(21):10465-10478. doi:10.1021/acsabm.6c01693
BibTeX
@article{Nordin2026,
author = {Nordin, Nurdiana and Shaharulnizam, M Arman and Zamlis, Marlin Alya and Bakar, Nurfarhanim Abu},
title = {Crosslinking-Dependent Structure–Transport–Function Relationships in Gelatin–Hyaluronic Acid Hydrogels for Wound-Fluid Management},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {21},
pages = {10465--10478},
doi = {10.1021/acsabm.6c01693}
}
EUVIMED